#caseoftheday Hepatic Encephalopathy
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2019 – Sep 2025Where it's discussed
-
News21 articles
-
Facebook14 posts
-
X / Twitter12 posts
-
YouTube4 videos
AI synopsis
What people are saying
Several discussions, such as mentions of lactulose and rifaximin for treating hepatic encephalopathy, reflect a positive attitude towards the guidelines, with language emphasizing helpfulness and clinical relevance. The tone combines technical language with practical insights, indicating a professional and engaged audience that values evidence-based management approaches.
Most discussions acknowledge the guidelines and recognize the importance of treatments like lactulose and rifaximin, indicating general agreement with the article's recommendations.
The use of clinical hashtags and references to management strategies suggest a high level of relevance and curiosity among peers.
Comments include specific mentions of treatment options and management pearls, showing active interest and deeper engagement.
While the conversations reinforce clinical practices, they do not indicate widespread paradigm shifts but emphasize the importance of the guidelines in treatment decisions.
Abstract in brief
- The guideline explains that hepatic encephalopathy (HE) is a decline in brain function caused by severe liver disease, which leads to the build-up of toxins like ammonia in the blood that the damaged liver can't filter out effectively.
- It emphasizes the importance of diagnosing HE early through clinical assessment and laboratory tests, along with identifying and treating any underlying liver issues or precipitating factors such as infections, gastrointestinal bleeding, or electrolyte imbalances.
- The guideline recommends comprehensive management strategies including medication (like lactulose and rifaximin), lifestyle modifications, and regular monitoring to improve quality of life and reduce the risk of recurrence in patients with chronic liver disease.]
Top posts
Most liked on X and BlueskyOvert hepatic encephalopathy (OHE), which can be seen in patients with cirrhosis, can be treated with lactulose, and rifaximin could be considered as add on to prevent OHE recurrence. #OTILT @BWDionne @raquelmp25 @yousraelhanaoui https://t.co/SkH9TlAEcm
[https://t.co/P87v73gpXN]
Dr. Mindikoglu concluding pearls on hepatic encephalopathy management @AASLDtweets @HEP_Journal https://t.co/21tNPoRQLf https://t.co/rY5Vt5HIwB
#PerlasClínicas #PerlasHepatología #PerlasMedicinaInterna #EncefalopatíaHepática [https://t.co/P87v73gpXN]
La American Association for the Study of Liver Diseases i la European Association for the Study of the Liver recomanaven el 2014, que el flumazenil podria ser d’utilitat per a evitar la ventilació mecànica en millorar transitòriament la gravetat de l’EH https://t.co/QeDiEkpclZ https://t.co/7iLzg3YvUs
All mentions
Identifying Early Signs of Liver Dysfunction
Early signs of liver dysfunction can manifest in various ways, often years before significant issues arise. Understanding these warning signals is essential in preventing severe conditions. This video explores the…
Understanding Liver Stress and Intestinal Health
Wut is often a sign of liver overload, particularly in Traditional Chinese Medicine. This video explores the connection between liver health and intestinal failure-associated liver disease (IFALD), emphasizing the…
Signs Your Liver Is Not Properly Detoxifying You
Hepatic Encephalopathy: Diagnosis and Management in Liver Disease
Hepatic encephalopathy is a decline in brain function caused by severe liver disease leading to toxin build-up. Diagnosis is clinical, and ammonia levels are not reliably predictive of disease state. Early detection and…
La American Association for the Study of Liver Diseases i la European Association for the Study of the Liver recomanaven el 2014, que el flumazenil podria ser d’utilitat per a evitar la ventilació mecànica en millorar transitòriament la gravetat de l’EH https://t.co/QeDiEkpclZ https://t.co/7iLzg3YvUs
RT @md_jramirez: [https://t.co/P87v73gpXN]
RT @md_jramirez: [https://t.co/P87v73gpXN]
[https://t.co/P87v73gpXN]
RT @md_jramirez: #PerlasClínicas #PerlasHepatología #PerlasMedicinaInterna #EncefalopatíaHepática [https://t.co/P87v73gpXN]
#PerlasClínicas #PerlasHepatología #PerlasMedicinaInterna #EncefalopatíaHepática [https://t.co/P87v73gpXN]
Overt hepatic encephalopathy (OHE), which can be seen in patients with cirrhosis, can be treated with lactulose, and rifaximin could be considered as add on to prevent OHE recurrence. #OTILT @BWDionne @raquelmp25 @yousraelhanaoui https://t.co/SkH9TlAEcm
Dr. Mindikoglu concluding pearls on hepatic encephalopathy management @AASLDtweets @HEP_Journal https://t.co/21tNPoRQLf https://t.co/rY5Vt5HIwB
RT @aldorodrigo: #caseoftheday Hepatic Encephalopathy
RT @aldorodrigo: #caseoftheday Hepatic Encephalopathy
RT @aldorodrigo: #caseoftheday Hepatic Encephalopathy
#caseoftheday Hepatic Encephalopathy